Catalent
CTLT
#1594
Rank
$8.59 B
Marketcap
$47.75
Share price
1.77%
Change (1 day)
-63.91%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Earnings for Catalent (CTLT)

Earnings in 2022 (TTM): $0.63 B

According to Catalent's latest financial reports the company's current earnings (TTM) are $0.63 B. In 2021 the company made an earning of $0.87 B an increase over its 2020 earnings that were of $0.49 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Catalent from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$0.63 B-27.41%
2021$0.87 B77.81%
2020$0.49 B62.33%
2019$0.30 B10.64%
2018$0.27 B18.66%
2017$0.23 B9.04%
2016$0.21 B-15.07%
2015$0.24 B15.39%
2014$0.21 B10.45%
2013$0.19 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$39.06 M-93.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-$77.63 M-112.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$23.25 M-103.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.18 B-128.07%๐Ÿ‡บ๐Ÿ‡ธ USA